- Home
- IMTX vs ECAT Comparison
IMTX vs ECAT Comparison
Compare IMTX & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$10.91
Company Overview
Basic Information| Metric | IMTX | ECAT |
|---|---|---|
| Founded | N/A | 2021 |
| Country | Germany | United States |
| Employees | 407 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMTX | ECAT |
|---|---|---|
| Price | $10.91 | $15.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 361.6K | ★ 562.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.91 | N/A |
| P/E Ratio | ★ N/A | $6.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $13.36 |
| 52 Week High | $12.41 | $17.14 |
Technical Indicators
Market Signals| Indicator | IMTX | ECAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 64.99 |
| Support Level | $9.66 | $14.92 |
| Resistance Level | $11.30 | $15.76 |
| Average True Range (ATR) | 0.49 | 0.26 |
| MACD | 0.13 | 0.20 |
| Stochastic Oscillator | 88.71 | 90.76 |
Price Performance
Historical Comparison IMTX
ECAT
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.